Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate KALA BIO, Inc. before investing.

In this article, we go over a few key elements for understanding KALA BIO, Inc.’s stock price such as:

• KALA BIO, Inc.’s current stock price and volume
• Why KALA BIO, Inc.’s stock price changed recently
• Upgrades and downgrades for KALA from analysts
• KALA’s stock price momentum as measured by its relative strength

About KALA BIO, Inc. (KALA)

Before we jump into KALA BIO, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Want to learn more about KALA BIO, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about KALA BIO, Inc..

KALA BIO, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, KALA BIO, Inc.’s stock price was $0.756.

KALA BIO, Inc. is up 3.59% from its previous closing price of $0.730.

During the last market session, KALA BIO, Inc.’s stock traded between $0.670 and $0.790. Currently, there are approximately 11.87 million shares outstanding for KALA BIO, Inc..

KALA BIO, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

KALA BIO, Inc. Stock Price History

KALA BIO, Inc.’s (KALA) price is currently down 56.31% so far this month.

During the month of July, KALA BIO, Inc.’s stock price has reached a high of $2.040 and a low of $0.590.

Over the last year, KALA BIO, Inc. has hit prices as high as $1,030.000 and as low as $0.590. Year to date, KALA BIO, Inc.’s stock is down 97.28%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused KALA BIO, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded KALA BIO, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate KALA BIO, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on KALA BIO, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about KALA BIO, Inc. (KALA) by visiting AAII Stock Evaluator.

Relative Price Strength of KALA BIO, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, KALA BIO, Inc. has a weighted four-quarter relative price strength of -75.30%, which translates to a Momentum Score of 0 and is considered to be Very Weak.

Want to learn more about how KALA BIO, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

KALA BIO, Inc. Stock Price: Bottom Line

As of July 31, 2026, KALA BIO, Inc.’s stock price is $0.756, which is up 3.59% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like KALA BIO, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.